Interview with Prof. Barbara Radecka, head of the Department of Oncology at the Prof. Tadeusz Koszarowski Oncology Center in Opole and Opole University.
What are the current needs of clinicians and their patients in relation to early breast cancer?
The best defined need at the moment is to introduce reimbursement for treatments that would be dedicated to patients with early, hormone-dependent breast cancer who have a high risk of recurrence. We in oncology define this risk based on the initial stage, so the size of the primary tumor, metastasis to the axillary lymph nodes, the degree of malignancy, a parameter related to cell proliferation. These are some characteristics ba...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
